Cervarix VaccineiconrnGlaxo SmithKline Pharmaceuticals LtdrnComposition for Cervarix VaccinernHuman Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (NA) Primary uses of Cervarix VaccinernPrevention of HPV-Associated CancersrnMRP₹2405rn₹2405/Suspension for Injectionrn0.5 ml in 1 prefilled syringe